News

Izmir Biomedicine and Genome Center (IBG): Research in life sciences in Turkey

Izmir Biomedicine and Genome Center (IBG): Research in life sciences in Turkey
Learn more about Izmir Biomedicine and Genome Center (IBG), the newest member to join our gobal community.
Partnerships and Growth
Member News

Izmir Biomedicine and Genome Center (IBG) is the first independent thematic Research Infrastructure in life sciences in Izmir, Türkiye. IBG’s main objective is to carry out powerful research on biomedicine and genome sciences, to develop products based on medical and pharmaceutical biotechnologies using its workforce and technical infrastructure, and thus, to contribute to global science and the transformation of national industry. IBG offers a broad range of research services for both academia and industry across various research fields under the below core facilities and technology platforms; Gene Targeting and Transgenic Models Platform, IBG-BIP, Bioinformatics Platform, IBG-Biobank, National node of BBMRI-ERIC, IBG-PHARMA, Drug Analysis and Control Laboratory, GLP-certified, IBG-NEVCELL, Cellular Therapies Platform, GMP Manufacturing Facility, Vivarium (Zebrafish &Rodent Unit), Rare and Undiagnosed Disease Platform. IBG has been coordinating two national high-technology platforms specializing in the design of novel adjuvants and vaccines, drug development and pan-cancer therapies.

 

As of 2023, IBG hosts 32 research groups in three main pillars (i) Basic and translational research program, (ii) Technological research program, (iii) Industrial R&D program with a research focus in the fields of cancer, genomics and bioinformatics, stem cells and regeneration, immunology and infectious diseases, rare and undiagnosed diseases, neuroscience and bioengineering.

 

IBG believes that fostering strong connections and collaborations is crucial for the success of our collective initiatives. IBG is interested in leveraging the diverse expertise within the ECHAlliance community to facilitate knowledge exchange, collaborative projects, and the sharing of best practices. Establishing robust networking channels would enable them to collectively address challenges, explore innovative solutions, and contribute to the advancement of healthcare and digital health initiatives. IBG looks forward to engaging with fellow members to build meaningful connections and collaborations that will benefit the entire community.

NEWS​

Related News

Finland – Kuopio Health Ecosystem is ECHAlliance Ecosystem of the Month – July

15 Jul 2024
This month we are featuring our Finland - Kuopio Health Ecosystem as our Ecosystem of the Month.

EU JAMRAI- 2: Building a One Health World

15 Jul 2024
The mission at EU-JAMRAI 2 is to lead the fight against antimicrobial resistance (AMR) through joint and coordinated action across Europe.

Team MediBoost Wins AI4Health.Cro Innovation Competition

15 Jul 2024
Team MediBoost clinched the top prize at this year’s AI4Health.Cro innovation competition, winning €5,000 for their groundbreaking application designe...

Tackling obesity

8 Jul 2024
Apply for funding to develop effective strategies to tackle overweight and obesity. ‘Tackling obesity’ is open to applications submitted to the Popula...

Cancer research transatlantic development and skills enhancement award 2024

4 Jul 2024
Following the UK-US Cancer Summit, MRC and NIHR, in partnership with NCI, are launching a second competition for the cancer research transatlantic dev...

24/52 Liver Disease (EME Programme)

4 Jul 2024
The Efficacy and Mechanism Evaluation (EME) Programme is accepting Stage 1 applications to this funding opportunity.

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *